Coxsackievirus A16

Qunying Mao; Yiping wang; Xin Yao; Lianlian Bian; Xing wu; Miao Xu; Zhenglun Liang
February 2014
Human Vaccines & Immunotherapeutics;Feb2014, Vol. 10 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • RISK ASSESSMENT of waterborne coxsackievirus. Mena, Kristina D.; Gerba, Charles P.; Haas, Charles N.; Rose, Joan B. // Journal: American Water Works Association;Jul2003, Vol. 95 Issue 7, p122 

    Focuses on a study which evaluated the potential public health effects associated with contaminated drinking and recreational water. Information on coxsackievirus; Diseases associated with coxsackieviruses; Occurrence of coxsackievirus in water; Survival rate for patients with coxsackievirus...

  • Ask Doctor Cory.  // Turtle;Oct/Nov2001, Vol. 23 Issue 7, p34 

    Presents information on the hand, foot and mouth disease caused by Coxsackievirus.

  • Progressive liver calcifications in neonatal coxsackievirus infection. Hoeffel, J.-C. // Pediatric Radiology;Oct2000, Vol. 30 Issue 11, p810 

    Presents a letter to the editor about liver calcification in neonatal coxsackievirus infection.

  • Immunopathology during coxsackievirus infection. Whitton, J. Lindsay // Springer Seminars in Immunopathology;Jun2002, Vol. 24 Issue 2, p201 

    Focuses on the coxsackievirus type B (CVB) group of viruses, which are more commonly associated with human disease. Immunopathology during coxsackievirus infection; Diseases associated with CVB infections.

  • Nutritionally induced oxidative stress: Effect on viral diseases. Beck, Melinda A. // American Journal of Clinical Nutrition;Jun2000 Supplement, Vol. 71, p1676S 

    Investigates the effects of nutritionally induced oxidative stress on viral diseases. Coxsackievirus infection in Selenium-deficient hosts; Vitamin E deficiency and Coxsackievirus infection; Influence of nutritional status of hosts on the activity of disease-causing virus.

  • 446 Predictors of clinical manifestations and courses in patients with acute fulminant coxsackievirus myocarditis.  // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p104 

    An abstract of the article "Predictors of Clinical Manifestations and Courses in Patients With Acute Fulminant Coxsackievirus Myocarditis," by D. K. Cho and colleagues, is presented.

  • 439 Tenascin-C expression as a marker for a Coxsackievirus B3 myocarditis. Ruppert, V.; Jonsdottir, T.; Pankuweit, S.; Maisch, B. // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p104 

    An abstract of the study "Tenascin-C expression as a marker for a Coxsackievirus B3 myocarditis," by V. Ruppert and colleagues, is presented.

  • Antiviral activity of coxsackievirus B3 3C protease inhibitor. Jeon, E.-S.; Yun, S.H.; Kim, D.K.; Cho, M.C.; Choi, D.J.; Kim, J.J.; Ryu, K.H. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p51 

    An abstract of the article "Antiviral activity of coxsackievirus B3 3C protease inhibitor," by E. S. Jeon and colleagues is presented.

  • Hand, Foot, and Mouth Disease Caused by Cox-sackievirus A6, Japan, 2011. Fujimoto, Tsuguto; Iizuka, Setsuko; Enomoto, Miki; Abe, Katsuhiko; Yamashita, Kazuyo; Hanaoka, Nozomu; Okabe, Nobuhiko; Yoshida, Hiromu; Yasui, Yoshinori; Kobayashi, Masaaki; Fujii, Yoshiki; Tanaka, Hiroko; Yamamoto, Miwako; Shimizu, Hiroyuki // Emerging Infectious Diseases;Feb2012, Vol. 18 Issue 2, p337 

    A letter to the editor is presented which reports cases of hand, foot, and mouth disease caused by Coxsackievirus A6 in Japan in 2011.

  • Obinutuzumab.  // Reactions Weekly;May2014, Vol. 1503 Issue 1, p32 

    An abstract of the article "Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium," by T. Eyckmans and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics